Description
A selective inhibitor of SPHK2 (Ki = 6.4 µM; IC50s = 4.3 and >10 µM for human recombinant SPHK2 and SPHK1, respectively); inhibits SPHK2 activity in U937 cells at 10 µM; inhibits tumor growth in a U937 mouse xenograft model at 15 mg/kg; improves glucose tolerance and regulates gluconeogenesis by stimulating insulin-dependent Akt/FoxO1 signaling in a mouse model of dexamethasone-induced insulin resistance at 30 mg/kg
Formal name: 3-(2-aminoethyl)-5Z-[3-(4-butoxyphenyl)propylidene]-2,4-thiazolidinedione, monohydrochloride
Synonyms:
Molecular weight: 384.9
CAS: 1449240-68-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Lipid Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling||Research Area|Cell Biology|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Lipid Biochemistry|Sphingolipids